PAR-23-248: Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
Closed
This grant is closed. A newer notice from the same program is open now: Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) (PAR-26-115). Status: Due dates in the notice, expires May 26, 2028. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on September 26, 2025.
From the official notice on Grants.gov, last changed August 1, 2023. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU2C
- Clinical trialsNot allowed
- Funded byNIDDK
- Median yearly award$190,663
- Typical project length4.5 years
Projects funded under PAR-23-248 were run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 24 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-23-248 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-26-115 | December 10, 2025 | Due dates in the notice, expires May 26, 2028 | Open |
Key dates
| Posted | August 1, 2023 |
|---|---|
| Deadline | September 26, 2025 |
| Archived by Grants.gov | November 1, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (70% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity is to invite Institutional Network Awards (U2C-TL1) to cultivate a highly integrated cohort of trainees and early career investigators and to develop career development resources to acceleratekidney, urologic, and hematologic research. To maximize integration and promote a true trainee community, Institutions are invited to submit a single, unified U2C-TL1 application to engage, recruit, prepare, and sustain the next generation of scientists able to contribute to advancing research in kidney, urology,and hematology. Applications representing multiple institutions within a single metropolitan area are strongly encouraged (see Section III.3).
Funded under PAR-23-248 so far
NIH funded 24 projects under PAR-23-248 in fiscal 2024 to 2026, at 12 institutions. The median yearly award was $190,663.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Network Core | Brigham and Women's Hospital | 2026 | $68,648 |
| Next Generation KUH Researchers (GENERATOR) | Mayo Clinic Rochester | 2026 | $368,742 |
| Administrative Core: Houston Area Incubator for Kidney, Urologic, and Hematologic Research Training (HAI-KUH) | Baylor College of Medicine | 2026 | $110,216 |
| Administration Core | University of Pennsylvania | 2026 | $290,849 |
| Administrative Core for Chicago KUH FORWARD | Northwestern University | 2026 | $273,499 |
| KUH-TN Professional Development Core | Cleveland Clinic Lerner Com-Cwru | 2026 | $30,764 |
| Professional Development Core | Yale University | 2026 | $43,727 |
| KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology | University of California Los Angeles | 2026 | $260,875 |
Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before
From fiscal 2021 to 2025, Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $9.6 billion across 7,877 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Michigan | 273 | $345 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 187 | $272 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 209 | $238 million |
| The Washington University | Missouri | 187 | $227 million |
| The Regents of the University of California, San Francisco | California | 176 | $208 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PAR-26-115, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-23-248 still open?
No. It closed on September 26, 2025. A newer notice is open: PAR-26-115, due dates in the notice, expires May 26, 2028.
Who can apply for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)?
Closed September 26, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-23-248?
NIH RePORTER lists 24 projects funded under PAR-23-248 in fiscal 2024 to 2026, at 12 institutions. The most were at Brigham and Women's Hospital, Mayo Clinic Rochester, Baylor College of Medicine.
Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before?
The largest recipients over five fiscal years were Regents of the University of Michigan, The Trustees of the University of Pennsylvania, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 7,877 awards worth $9.6 billion in that time.
Similar open grants
- Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)
- NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional)
- Health and Extreme Weather Research Coordination and Data Center (U2C - Clinical Trial Not Allowed)
- Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)